← SynDRA
NP-G2-044
SynDRA canonical compound SYN0039619 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Primary target(s) | PDCD1 |
| Indication | breast cancer |
| Disease area | oncology |
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- 1ER2O3UZ4W
- UNII-1ER2O3UZ4W
- SCHEMBL17038863
- 3-Furancarboxamide, 2-methyl-N-(1-((4-(trifluoromethyl)phenyl)methyl)-1H-indazol-3-yl)-
- 2-Methyl-N-(1-((4-(trifluoromethyl)phenyl)methyl)-1H-indazol-3-yl)-3-furancarboxamide
- NP G2 044
- RefChem:166895
- Fascin Inhibitor NP-G2-044
- DTXCID301558798
- orb1298364
- SCHEMBL30501127
- SCHEMBL30501132
- XLLRLAABUFOJPC-UHFFFAOYSA-N
- EX-A3988
- s2962
- AKOS040759669
- NP-G2-044?
- DA-66206
- MS-26765
- HY-125506
- CS-0092083
- T9107
- G17429
Look up NP-G2-044 in the interactive SynDRA portal →